Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Castle Biosciences Inc

CSTL
Current price
22.92 USD +0.24 USD (+1.06%)
Last closed 22.68 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 594 935 168 USD
Yield for 12 month +73.90 %
1Y
3Y
5Y
10Y
15Y
CSTL
21.11.2021 - 28.11.2021

Castle Biosciences, Inc., a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. In addition, the company provides DecisionDx-UM test, a proprietary risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide drug treatment for major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. It offers its products to skin cancer, gastroenterology, and mental health markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas. Address: 505 South Friendswood Drive, Friendswood, TX, United States, 77546

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

34.33 USD

P/E ratio

Dividend Yield

Current Year

+219 788 000 USD

Last Year

+137 039 000 USD

Current Quarter

+72 974 000 USD

Last Quarter

+66 120 000 USD

Current Year

+164 234 000 USD

Last Year

+105 030 000 USD

Current Quarter

+56 395 000 USD

Last Quarter

+51 026 000 USD

Key Figures CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -29 148 000 USD
Operating Margin TTM -7.5 %
PE Ratio
Return On Assets TTM -5.92 %
PEG Ratio
Return On Equity TTM -7.82 %
Wall Street Target Price 34.33 USD
Revenue TTM 250 724 992 USD
Book Value 14.59 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 73.6 %
Dividend Yield
Gross Profit TTM 105 030 000 USD
Earnings per share -1.13 USD
Diluted Eps TTM -1.13 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -92.6 %
Profit Margin -12.28 %

Dividend Analytics CSTL

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CSTL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.4816
Price Sales TTM 2.5179
Enterprise Value EBITDA -7.2324
Price Book MRQ 1.4144

Financials CSTL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSTL

For 52 weeks

12.07 USD 25.91 USD
50 Day MA 22.37 USD
Shares Short Prior Month 1 293 588
200 Day MA 20.11 USD
Short Ratio 5.24
Shares Short 1 145 890
Short Percent 4.83 %

Dynamics of changes in the value of assets

Stocks


AAPL

AAPL

212.49 USD Apple Inc -1.32 (-0.62%)
Detailed analytics

ETF funds


S

SX7EEX

13.36 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) -0.53 (-3.54%)
Detailed analytics

Metals


Gold

2332.52 USD Gold +27.54 (+1.2%)
Detailed analytics